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Protein quantification without isotopic labels has been a
long-standing interest in the proteomics field. However,
accurate and robust proteome-wide quantification with la-
bel-free approaches remains a challenge. We developed a
new intensity determination and normalization procedure
called MaxLFQ that is fully compatible with any peptide or
protein separation prior to LC-MS analysis. Protein abun-
dance profiles are assembled using the maximum possible
information from MS signals, given that the presence of
quantifiable peptides varies from sample to sample. For a
benchmark dataset with two proteomes mixed at known
ratios, we accurately detected the mixing ratio over the
entire protein expression range, with greater precision for
abundant proteins. The significance of individual label-free
quantifications was obtained via a t test approach. For a
second benchmark dataset, we accurately quantify fold
changes over several orders of magnitude, a task that is
challenging with label-basedmethods. MaxLFQ is a generic
label-free quantification technology that is readily applica-
ble to many biological questions; it is compatible with
standard statistical analysis workflows, and it has been
validated in many and diverse biological projects. Our algo-
rithms can handle very large experiments of 500 samples
in a manageable computing time. It is implemented in the
freely available MaxQuant computational proteomics plat-
form and works completely seamlessly at the click of a
button. Molecular & Cellular Proteomics 13: 10.1074/mcp.
M113.031591, 2513–2526, 2014.
Mass-spectrometry-based proteomics has become an in-
creasingly powerful technology not only for the identification
of large numbers of proteins, but also for their quantification
(1–3). Modern mass spectrometer hardware, in combination
with increasingly sophisticated bioinformatics software for
data analysis, is now ready to tackle the proteome on a global,
comprehensive scale and in a quantitative fashion (4–6).
Stable isotope-based labeling methods are the gold stand-
ard for quantification. However, despite their success, they
inherently entail extra preparation steps, whereas label-free
quantification is by its nature the simplest and most econom-
ical approach. Label-free quantification is in principle appli-
cable to any kind of sample, including materials that cannot
be directly metabolically labeled (for instance, many clinical
samples). In addition, there is no limit on the number of
samples that can be compared, in contrast to the finite num-
ber of “plexes” available for label-based methods (7).
A vast literature on label-free quantification methods, re-
viewed in Ref. 3 and Refs. 8–13, and associated software
projects (14–31) already exist. These computational methods
include simple additive prescriptions to combine peptide in-
tensities (32, 33), reference-peptide-based estimates (34),
and statistical frameworks utilizing additive linear models (35,
36). However, major bottlenecks remain: Most methods re-
quire measurement of samples under uniform conditions with
strict adherence to standard sample-handling procedures,
with minimal fractionation and in tight temporal sequence.
Also, many methods are tailored toward a specific biological
question, such as the detection of protein interactions (37),
and are therefore not suitable as generic tools for quantifica-
tion at a proteome scale. Finally, the modest accuracy of their
quantitative readouts relative to those obtained with stable-
isotope-based methods often prohibits their use for biological
questions that require the detection of small changes, such as
proteome changes upon stimulus.
Metabolic labeling methods such as SILAC1 (38) excel be-
cause of their unparalleled accuracy and robustness, which
are mainly due to stability with regard to variability in sample
processing and analysis steps. When isotope labels are intro-
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duced early in the workflow, samples can be mixed, and any
sample-handling issues equally affect all proteins or peptides.
This allows complex biochemical workflows without loss of
quantitative accuracy. Conversely, any up-front separation of
proteins or peptides potentially poses serious problems in a
label-free approach, because the partitioning into fractions is
prone to change slightly in the analysis of different samples.
Chemical labeling (39–41) is in principle universally applica-
ble, but because the labels are introduced later in the sample
processing, some of the advantages in robustness are lost.
Depending on the label used, it can also be uneconomical for
large studies.
High mass resolution and accuracy and high peptide iden-
tification rates have been key ingredients in the success of
isotope-label-based methods. These factors contribute simi-
larly to the quality of label-free quantification. An increased
identification rate directly improves label-free quantification
because it increases the number of data points and allows
“pairing” of corresponding peptides across runs. Although
high mass accuracy aids in the identification of peptides (42),
it is the high mass resolution that is crucial to accurate quan-
tification. This is because the accurate determination of ex-
tracted ion currents (XICs) of peptides is critical for compari-
son between samples (43). At low mass resolution, XICs of
peptides are often contaminated by nearby peptide signals,
preventing accurate intensity readouts. In the past, this has
led many researchers to use counts of identified MS/MS
spectra as a proxy for the ion intensity or protein abundance
(44). Although the abundance of proteins and the probability
of their peptides being selected for MS/MS sequencing are
correlated to some extent, XIC-based methods should clearly
be superior to spectral counting given sufficient resolution
and optimal algorithms. These advantages are most promi-
nent for low-intensity protein/peptide species, for which a
continuous intensity readout is more information-rich than
discrete counts of spectra. Therefore, we here apply the term
“label-free quantification” strictly to XIC-based approaches
and not to spectral counting.
In this manuscript, we describe the MaxLFQ algorithms,
part of the MaxQuant software suite, that solve two of the
main problems of label-free protein quantification. We intro-
duce “delayed normalization,” which makes label-free quan-
tification fully compatible with any up-front separation. Fur-
thermore, we implemented a novel approach to protein
quantification that extracts the maximum ratio information
from peptide signals in arbitrary numbers of samples to
achieve the highest possible accuracy of quantification.
MaxLFQ is a generic method for label-free quantification
that can be combined with standard statistical tests of quan-
tification accuracy for each of thousands of quantified pro-
teins. MaxLFQ has been available as part of the MaxQuant
software suite for some time and has already been success-
fully applied to a variety of biological questions by us and
other groups. It has delivered excellent performance in bench-
mark comparisons with other software solutions (31).
EXPERIMENTAL PROCEDURES
Proteome Benchmark Dataset—An Escherichia coli K12 strain was
grown in standard LB medium, harvested, washed in PBS, and lysed
in BugBuster (Novagen Merck Chemicals, Schwalbach, Germany)
according to the manufacturer’s protocol. HeLa S3 cells were grown
in standard RPMI 1640 medium supplemented with glutamine, anti-
biotics, and 10% FBS. After being washed with PBS, cells were lysed
in cold modified RIPA buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150
mM NaCl, 1% N-octylglycoside, 0.1% sodium deoxycholate, com-
plete protease inhibitor mixture (Roche)) and incubated for 15 min on
ice. Lysates were cleared by centrifugation, and after precipitation
with chloroform/methanol, proteins were resuspended in 6 M urea,
2 M thiourea, 10 mM HEPES, pH 8.0. Prior to in-solution digestion,
60-g protein samples from HeLa S3 lysates were spiked with either
10 g or 30 g of E. coli K12 lysates based on protein amount
(Bradford assay). Both batches were reduced with dithiothreitol and
alkylated with iodoacetamide. Proteins were digested with LysC
(Wako Chemicals, GmbH, Neuss, Germany) for 4 h and then trypsin
digested overnight (Promega, GmbH, Mannheim, Germany). Diges-
tion was stopped by the addition of 2% trifluroacetic acid. Peptides
were separated by isoelectric focusing into 24 fractions on a 3100
OFFGEL Fractionator (Agilent, GmbH, Böblingen, Germany) as de-
scribed in Ref. 45. Each fraction was purified with C18 StageTips (46)
and analyzed via liquid chromatography combined with electrospray
tandem mass spectrometry on an LTQ Orbitrap (Thermo Fisher) with
lock mass calibration (47). All raw files were searched against the
human and E. coli complete proteome sequences obtained from
UniProt (version from January 2013) and a set of commonly observed
contaminants. MS/MS spectra were filtered to contain at most eight
peaks per 100 mass unit intervals. The initial MS mass tolerance was
20 ppm, and MS/MS fragment ions could deviate by up to 0.5 Da (48).
For quantification, intensities can be determined alternatively as the
full peak volume or as the intensity maximum over the retention time
profile, and the latter method was used here as the default. Intensities
of different isotopic peaks in an isotope pattern are always summed
up for further analysis. MaxQuant offers a choice of the degree of
uniqueness required in order for peptides to be included for quanti-
fication: “all peptides,” “only unique peptides,” and “unique plus razor
peptides” (42). Here we chose the latter, because it is a good com-
promise between the two competing interests of using only peptides
that undoubtedly belong to a protein and using as many peptide
signals as possible. The distribution of peptide ions over fractions and
samples is shown in supplemental Fig. S1.
Dynamic Range Benchmark Dataset—The E. coli K12 strain was
grown in standard LB medium, harvested, washed in PBS, and lysed
in 4% SDS, 100 mM Tris, pH 8.5. Lysates were briefly boiled and DNA
sheared using a Sonifier (Branson Model 250). Lysates were cleared
by centrifugation at 15,000  g for 15 min and precipitated with
acetone. Proteins were resuspended in 8 M urea, 25 mM Tris, pH 8.5,
10 mM DTT. After 30 min of incubation, 20 mM iodoacetamide was
added for alkylation. The sample was then diluted 1:3 with 50 mM
ammonium bicarbonate buffer, and the protein concentration was
estimated via tryptophan fluorescence emission assay. After 5 h of
digestion with LysC (Wako Chemicals) at room temperature, the
sample was further diluted 1:3 with ammonium bicarbonate buffer,
and trypsin (Promega) digestion was performed overnight (protein-to-
enzyme ratio of 60:1 in each case). E. coli peptides were then purified
by using a C18 Sep Pak cartridge (Waters, Milford, MA) according to
the manufacturer’s instructions. UPS1 and UPS2 standards (Sigma-
Aldrich) were resuspended in 30 l of 8 M urea, 25 mM Tris, pH 8.5, 10
mM DTT and reduced, alkylated, and digested in an analogous man-
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ner, but with a lower protein-to-enzyme ratio (12:1 for UPS1 and 10:1
for UPS2, both LysC and trypsin). UPS peptides were then purified
using C18 StageTips. E. coli and UPS peptides were quantified based
on absorbance at 280 nm using a NanoDrop spectrophotometer
(Fisher Scientific). For each run, 2 g of E. coli peptides were then
spiked with 0.15 g of either UPS1 or UPS2 peptides, and about 1.6
g of the mix was then analyzed via liquid chromatography combined
with mass spectrometry on a Q Exactive (Thermo Fisher). Data were
analyzed with MaxQuant as described above for the proteome dataset.
All files were searched against the E. coli complete proteome se-
quences plus those of the UPS proteins and common contaminants.
Retention Time Alignment and Identification Transfer—To increase
the number of peptides that can be used for quantification beyond
those that have been sequenced and identified by an MS/MS data-
base search engine, one can transfer peptide identifications to
unsequenced or unidentified peptides by matching their mass and
retention times (“match-between-runs” feature in MaxQuant). A pre-
requisite for this is that retention times between different LC-MS runs
be made comparable via alignment. The order in which LC-MS runs
are aligned is determined by hierarchical clustering, which allows one
to avoid reliance on a single master run. The terminal branches of the
tree from the hierarchical clustering typically connect LC-MS runs of
the same or neighboring fractions or replicate runs, as they are the
most similar. These cases are aligned first. Moving along the tree
structure, increasingly dissimilar runs are integrated. The calibration
functions that are needed to completely align LC-MS runs are usually
time-dependent in a nonlinear way. Every pair-wise alignment step is
performed via two-dimensional Gaussian kernel smoothing of the
mass matches between the two runs. Following the ridge of the
highest density region determines the recalibration function. At each
tree node the resulting recalibration function is applied to one of the
two subtrees, and the other is left unaltered.
Unidentified LC-MS features are then assigned to peptide identifi-
cations in other runs that match based on their accurate masses and
aligned retention times. In complex proteomes, the high mass accu-
racy on current Orbitrap instruments is still insufficient for an unequiv-
ocal peptide identification based on the peptide mass alone. How-
ever, when comparing peptides in similar LC-MS runs, the information
contained in peptide mass and recalibrated retention time is enough
to transfer identifications with a sufficiently low FDR (in the range of
1%), which one can estimate by comparing the density of matches
inside the match time window to the density outside this window (49).
The matching procedure takes into account the up-front separa-
tion, in this case isoelectric focusing of peptides into 24 fractions.
Identifications are only transferred into adjacent fractions. If, for in-
stance, for a given peptide sequenced in fraction 7, isotope patterns
are found to match by mass and retention time in fractions 6, 8, and
17, the matches in fraction 17 are discarded because they have a
much greater probability of being false. The same strategy can be
applied to any other up-front peptide or protein separation (e.g.
one-dimensional gel electrophoresis). All matches with retention time
differences of less than 0.5 min after recalibration are accepted.
Further details on the alignment and matching algorithms, including
how to control the FDR of matching, will be described in a future
manuscript.
Software and Data Availability—The label-free software MaxLFQ is
completely integrated into the MaxQuant software (42) and can be
activated by one additional click. It is freely available to academic and
commercial users as part of MaxQuant and can be downloaded via
the Internet. MaxQuant runs on Windows desktop computers with
Vista or newer operating systems, preferably the 64-bit versions.
There is a large user community at the MaxQuant Google group.
All downstream analysis was done using our in-house developed
Perseus software, which is also freely available from the MaxQuant
website.
The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository with the
dataset identifier PXD000279.
RESULTS
Proteome-wide Benchmark Dataset—Evaluation of the ac-
curacy of a label-free workflow at a proteome scale requires a
dataset with known ratios. To this end we produced a bench-
mark dataset by mixing whole, distinguishable proteomes in
defined ratios. Combined trypsin-digested lysates of HeLa
cells and E. coli cells were extensively separated via isoelec-
tric focusing into 24 fractions as described (45) and analyzed
via LC-MS/MS in three replicates (“Experimental Proce-
dures”). This was repeated with the same quantity of HeLa,
but admixed with a 3-fold increased amount of E. coli lysate.
In the resulting six samples all human proteins therefore
should have had one-to-one ratios and all E. coli proteins
should have had a ratio of three to one between replicate
groups.
Raw data were processed with MaxQuant (42) and its
built-in Andromeda search engine (50) for feature extraction,
peptide identification, and protein inference. Peptide and pro-
tein FDRs were both set at 1%. MaxQuant identified a total of
789,978 isotope clusters through MS/MS sequencing. Trans-
ferring identifications to other LC-MS runs by matching them
to unidentified features based on their masses and recali-
brated retention times increased the number of quantifiable
isotope patterns more than 2-fold (“match-between-runs,”
“Experimental Procedures”).
A Novel Solution to the Normalization Problem—A major
challenge of label-free quantification with prefractionation is
that separate sample processing inevitably introduces differ-
ences in the fractions to be compared. In principle, correct
normalization of each fraction can eliminate this error. How-
ever, the total peptide ion signals, necessary in order to
perform normalization of the LC MS/MS runs of each fraction,
are spread over several adjacent runs. Therefore one cannot
sum up the peptide ion signals before one knows the normal-
ization coefficients for each fraction.
We solve this dilemma by delaying normalization. After
summing up intensities with normalization factors as free
variables, we determine their quantities via a global optimiza-
tion procedure based on achieving the least overall proteome
variation.
Formally, we want to determine normalization coefficients
Nj, which multiply all intensities in the jth LC-MS run (j runs
from 1 to 144 in our example). The normalization is done
purely from the data obtained and without the addition of
external quantification standards or reliance on a fixed set of
“housekeeping” proteins. Directly adjusting the normalization
coefficients Nj for each of the fractions so that the total signal
Label-free Quantification in MaxQuant
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is equalized leads to errors if the fractionation is slightly irre-
producible or if the mass spectrometric responses in the jth
run are different from average. Therefore, we wish to summa-
rize the peptide ion signals over the fractions in each sample.
This, however, already requires the determination of the run-
specific normalization factors Nj. We exploit the fact that the
majority of the proteome typically does not change between
any two conditions so that the average behavior can be used
as a relative standard. This concept is also applied in label-
based methods (e.g. for the normalization of SILAC ratios in
MaxQuant). After summing the peptide ion signals across
fractions with as-yet unknown Nj factors, we determined
these factors in a nonlinear optimization model that minimized
overall changes for all peptides across all samples (Fig. 1). For





where the index k runs over all isotope patterns for peptide ion
P in sample A. Here, different charge modification states are
treated separately. The sum is understood as a generalized
summation that can be the regular sum or the maximum over
fractions. Also, for the XIC several choices exist, including
total three-dimensional peak volume or area of the cross-
section at the retention time when the maximum intensity is








is the sum of all squared logarithmic fold changes between all
samples and summed over all peptide ions (see Fig. 1). We
minimized H(N) numerically with respect to the normalization
coefficients Nj via Levenberg–Marquardt optimization (51) in
order to achieve the least possible amount of differential
regulation for the bulk of the proteins. This procedure is
compatible with any kind of prefractionation and also is in-
sensitive toward irreproducibility in processing. The compu-
tational effort for this procedure grows quadratically with the
number of samples to be compared, which may hamper the
analysis of very large datasets containing hundreds of sam-
ples. In these cases, however, a heuristic may be employed to
estimate normalization coefficients by considering only a sub-
set of possible pair-wise combinations of samples (see sub-
section “Fast Label-free Normalization of Large Datasets”). In
principle, weighting factors can be included in the sum for
H(N) in order to penalize low-intensity ions. Here we refrained
from this in order to keep the parameterization of the model
simple.
Extraction of Maximum Peptide Ratio Information—Another
principal problem in label-free quantification is the selection of
the peptide signals that should contribute to the optimal de-
termination of the protein signal across the samples. A simple








IP,A(N) = NA,6XICA,6 + NA,7 XICA,7 + NA,8XICA,8
IP,B(N) = NB,5XICB,5 + NB,6 XICB,6 + NB,7XICB,7 + NB,8XICB,8
IP,C(N) = NC,7XICC,7 + NC,8 XICC,8 + NC,9XICC,9
IP,D(N) = ND,5XICD,5 + ND,6 XICD,6 + ND,7XICD,7
IP,E(N) = NE,6XICE,6 + NE,7XICE,7







IQ,A(N) = NA,14XICA,14 + NA,15 XICA,15 + NA,16 XICA,16
IQ,B(N) = NB,13XICB,13 + NB,14 XICB,14 + NB,15 XICB,15 + NB,16 XICB,16
IQ,C(N) = NC,13XICC,13 + NC,14 XICC,14 + NC,15 XICC,15
IQ,D(N) = ND,14XICD,14 + ND,15 XICD,15
IQ,E(N) = NE,14 XICE,14 + NE,15XICE,15 + NE,16XICE,16






IR,A(N) = NA,21XICA,21 + NA,22 XICA,22
IR,B(N) = NB,19XICB,19 + NB,20 XICB,20 + NB,21 XICB,21
IR,C(N) = NC,20XICC,20 + NC,21 XICC,21 + NC,22 XICC,22
IR,D(N) = ND,20XICD,20 + ND,21 XICD,21
IR,E(N) = NE,19 XICE,19 + NE,20 XICE,20 + NE,21XICE,21
IR F(N) = NF 20 XICF 20 + NF 21XICF 21
(     ) 
(     ) (     ) |          | IP,A(N)IP,B(N)( ) 
:
, , , , ,
log
2
+HP(N) = |     | IP,A(N)IP,C(N)log
2
+ |     | IP,A(N)IP,D(N)log
2
+ other sample pairs 
(     ) (     ) |     | IQ,A(N)IQ,B(N)log
2
+HQ(N) = |     | IQ,A(N)IQ,C(N)log
2
+ |     | IQ,A(N)IQ,D(N)log
2
+ other sample pairs 
(     ) (     ) (     ) |     | IR,A(N)IR,B(N)log
2
+HR(N) = |     | IR,A(N)IR,C(N)log
2
+ |     | IR,A(N)IR,D(N)log
2
+ other sample pairs 
H(N) = HP(N) + HQ(N) + HR(N) + other peptides
FIG. 1. Schematic construction of
the function H(N) to be minimized in
order to determine the normalization
coefficients for each LC-MS/MS run.
Intensity distributions of three peptides
(orange, green, and red) over samples
and fractions are indicated by the sizes
of the circles. H(N) is the sum of the
squared logarithmic changes in all sam-
ples (A, B, C, . . .) for all peptides (P, Q,
R, . . .). When using the fast normaliza-
tion option, only a subset of all possible
pairs of samples will be considered.
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solution to this problem is to add up all peptide signals for
each protein and then compare protein ratios. Alternatively,
peptide intensities may be averaged, or only the top n intense
species may be taken (31). However, these solutions discard
the individual peptide ratios and thus do not extract the max-
imum possible quantification information. Instead, ratios de-
rived from individual peptide signals should be taken into
account, rather than a sum of intensities, because the XIC
ratios for each peptide are already a measurement of the
protein ratio. The very same concept is applied in label-based
methods such as SILAC and contributes to their accuracy.
Due to stochastic MS/MS sequencing and differences in
protein abundances across samples, peptide identifications
are often missing in specific samples. One way to neverthe-
less obtain a signal for each peptide in every sample is to
integrate the missing peptide intensities over the mass reten-
tion time plane using the integration boundaries from the
samples in which the peptide has been identified. In this case,
noise level effectively substitutes for the signal. Care has to be
taken not to under- or overestimate the true ratios in either
of these approaches. Yet another possibility is to restrict
quantification to peptides that have a signal in all samples.
Although this works well when comparing two samples, it
becomes impractical when the number of samples is large—
for example, requiring a peptide signal to be present in all of
100 clinical samples would likely eliminate nearly all peptides
from quantification.
We propose a novel method for protein quantification that
does not suffer from the problems described above (Fig. 2).
We want to use only common peptides for pair-wise ratio
determination without losing scalability for large numbers of
samples. We achieve this for each protein by first calculating
its ratio between any two samples using only peptide species
that are present in both (Figs. 2A and 2B). Then the pair-wise
protein ratio is calculated as follows, taking the pair-wise ratio
of the protein in samples B and C in Fig. 2 as an example: First
the intensities of peptides occurring in both samples are
employed to calculate peptide ratios. In this case, peptide
FIG. 2. Algorithm constructing protein intensity profiles for one protein from its peptide signals. A, an exemplary protein sequence.
Peptides with an XIC-based quantification are indicated in magenta. B, the five peptide sequences give rise to seven peptide species. For this
purpose, a peptide species is a distinct combination of peptide sequence, modification state, and charge, each of which has its own
occurrence pattern over the different samples. C, occurrence matrix of peptide species in the six samples. D, matrix of pair-wise sample protein
ratios calculated from the peptide XIC ratios. Valid/invalid ratios are colored in green/red based on a configurable minimum ratio count cut-off.
If a sample has no valid ratio with any other sample, like sample F, the intensity will be set to zero. E, system of equations that needs to be
solved for the protein abundance profile. F, the resulting protein abundance profile for one protein. The absolute scale is adapted to match the
summed-up raw peptide intensities.
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species P2, P3, and P6 are shared (Fig. 2C). The pair-wise
protein ratio rCB (Fig. 2D) is then defined as the median of
the peptide ratios, to protect against outliers. We then pro-
ceed to determine all pair-wise protein ratios. In the example
in Fig. 2, we require a minimal number of two peptide ratios in
order for a given protein ratio to be considered valid. This
parameter is configurable in the MaxQuant software. Setting a
higher threshold will lead to more accurate quantitative val-
ues, at the expense of more missing values.
At this point we have constructed a triangular matrix contain-
ing all pair-wise protein ratios between any two samples, which
is the maximal possible quantification information. This matrix
corresponds to an overdetermined system of equations for the
underlying protein abundance profile (IA, IB, IC, . . .) across the
samples (Fig. 2E). We perform a least-squares analysis to re-
construct the abundance profile optimally satisfying the individ-




log rj,k  log Ij  log Ik2. (Eq. 3)
Then we rescale the whole profile to the cumulative inten-
sity across samples, thereby preserving the total summed
intensity for a protein over all samples (Figs. 2E and 2F). This
procedure is repeated for all proteins, resulting in an accurate
abundance profile for each protein across the samples. The
computational effort grows quadratically with the number of
samples in which a protein is present; however, it is readily
parallelizable at the protein level.
All resulting profiles are written into the MaxQuant output
tables in columns starting with “LFQ intensity.”
Quantification Results for the Proteome Benchmark
Set—To apply the algorithms to the E. coli and HeLa cell
mixture, we required a protein to have non-zero intensity in
two out of the three replicates for each condition. In addition,
protein groups had to be unambiguously assignable to one
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FIG. 3. Quantification results for
the proteome benchmark dataset.
Replicate groups were filtered for two
out of three valid values and averaged,
and the log ratios of the E. coli (orange)/
human (blue) 3:1 versus 1:1 samples
were plotted against the logarithm of
summed peptide intensities from the 1:1
sample as a proxy for absolute protein
abundance. A, quantification using
spectral counts. B, quantification using
summed peptide intensities. C, quantifi-
cation using MaxLFQ. D–F, same as
A–C, but colored using density estima-
tion. G, H, histograms of the ratio distri-
butions of human and E. coli proteins
obtained using the different quantifica-
tion methods.
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species; this was the case for 3453 human and 1556 E. coli
proteins (supplemental Table S1). In Fig. 3, we compare the
performance of MaxLFQ against that of two other frequently
used quantitative metrics: spectral counting and summed
peptide intensities. Both were also extracted by MaxQuant,
so we do not introduce biases due to the search engine and
the set of identified peptides, and only benchmark conceptu-
ally different metrics of quantification. For each case, we
averaged the three replicates of each experimental condition
and plotted the log ratios against the log of the summed
peptide intensity, which can be used as a proxy for absolute
protein abundance (52–54). In all cases, human and E. coli
proteins formed distinct clouds, but with different degrees of
overlap. Spectral count ratio clouds were clearly separated
only for the most abundant proteins (Figs. 3A and 3D). In the
low-intensity region, spectral counts became discrete values,
and their log ratios adopted a very wide distribution with
pronounced overlap of human and E. coli proteins. Further-
more, a systematic distortion was observable that resulted in
a general overestimation of the ratios of low-intensity pro-
teins. Ratios of summed peptide intensities already allowed
almost complete separation of human and E. coli proteins
across the entire abundance range, with some overlap occur-
ring only in the lower half (Figs. 3B and 3E). This demonstrates
a clear advantage of intensity-based approaches. When we
used our MaxLFQ algorithm, the overlap of the populations
was further reduced relative to the summed intensity ap-
proach, and the number of extreme outliers was markedly
reduced (Figs. 3C and 3F). We quantified the widths of the
distributions and the degree of overlap (Figs. 3G–3I), which
demonstrated that MaxLFQ performed best not only by gen-
erating the narrowest distributions, but also by most accu-
rately recapitulating the expected fold change of three be-
tween the population averages.
MaxLFQ has the prerequisite that a majority population of
proteins exists that is not changing between the samples.
How big this population needs to be and what the conse-
quences are if the changing population becomes comparable
in size to the non-changing one can be seen in the benchmark
dataset itself, in which the changing (E. coli) population com-
prised 31% of the proteins measured in total. MaxLFQ still
operated well under these circumstances. The average factor
of three between the changing and non-changing population
was recovered well. The only effect of the large size of the
changing population was a total shift of all log-ratios such that
the non-changing population was centered not exactly at zero
but at slightly negative values. However, this had no effect on
subsequent tests for finding differentially expressed proteins,
as they are all insensitive to global shifts of all values. Regard-
ing samples involving enrichment steps, we refer to our ex-
amples of interaction proteomics studies, in which MaxLFQ
performed very well. In such datasets, enriched proteins may
constitute a large part of the total protein mass (or peak
intensity). Still, we routinely observed a dominant population
of background binding proteins contributing a large number of
peptide features that changed minimally between experimen-
tal conditions (even if their intensities were lower). In large
pulldown datasets, the background population does not have
to be the same over all samples and can be a different one in
each pair-wise sample comparison in MaxLFQ.
Analysis at a population level does not in itself provide
statistically sound information on the regulation state of indi-
vidual proteins. In fact, Fig. 3B shows several human proteins
that appear to be changing by several-fold. In a clinical con-
text these might have been mistaken for biomarkers without
further analysis. We therefore explored different strategies to
retrieve significantly changing proteins based either on simple
fold change or on the variance of their quantitative signals,
ranking the proteins by their highest apparent fold change
(highest ratio of average intensities), by their standard t test p
value, by their Welch modified t test p value, and finally by
their Wilcoxon–Mann–Whitney p value. Because we had full
prior knowledge about which proteins were changing (only the
E. coli ones), we independently knew the FDR and could
construct precision-recall curves for each case to assess
performance (Fig. 4A). This revealed that retrieving proteins by
ratio (corresponding to a fixed fold change cut-off) was the
worst strategy. It had low precision even at small recall values
because of its sensitivity to outlier ratios in individual repli-
cates. When sorting proteins by ratios, we found that the
fourth protein was a false positive (Fig. 4B, arrow). The
Wilcoxon–Mann–Whitney test performed better but also had
problems at low recall. Both versions of the t test performed
significantly better, and the Welch modified t test was slightly
better than the standard t test. At a precision of 0.98, 72% of
the E. coli proteins were recalled. With a precision of 95%,
which is often used in similar circumstances, the vast majority
(88%) of E. coli proteins were retrieved when we used the
Welch modified t test.
In datasets of practical interest, the true proportion of false
positives is not known a priori. As a means to control the FDR
and solve potential multiple hypothesis testing problems in
real biological datasets, we usually apply permutation-based
methods for calculating q-values and global FDRs. These
robust strategies have been successfully applied to high-
throughput biological data for a long time (55). The advantage
of permutation-based methods is that no assumptions need
to be made regarding the parametric distributions of intensi-
ties or ratios. The significance analysis of microarrays (SAM)
method that we apply to most of the biological datasets also
utilizes moderation to ensure the stability of the results.
Whereas in most real applications the stabilization parameter
s0 introduced in Ref. 55 is beneficial, in this particular bench-
mark dataset it did not improve the performance relative to
the original t test statistic. This is presumably because in the
benchmark dataset all true ratios were either 1:1 or 1:3,
whereas in real applications the true ratio distribution has a
dense spectrum of small changes.
Label-free Quantification in MaxQuant
Molecular & Cellular Proteomics 13.9 2519
Interestingly, about one-third of the proteome was chang-
ing in the benchmark dataset, which is a large amount, con-
sidering that the normalization was based on the assumption
of a dominating population of non-changing proteins. The
effect of this can be observed in Fig. 3I. The center of the 1:1
population is shifted to slightly negative values. However, the
distance between the means of the 3:1 and 1:1 populations is
near the correct value of log2(3). Such a global shift of all
ratios will not affect statistical testing, as a test such as the t
test is insensitive to such a global shift of all values. If one
insists on having a 1:1 distribution centered exactly at 0, one
can apply another normalization step in which one subtracts
the most frequent value (i.e. the position of the global
maximum).
So far we have assessed the measurability of 3:1 changes
over the whole accessible dynamic range of protein abun-
dances. Another question of interest is how measurable
smaller ratios are. For this purpose we conducted an in silico
experiment in which the results of the actual 3:1 experiment
were rescaled in order to mimic results obtained with lower
mixing ratios. We rescaled the log ratios of all E. coli proteins
in the three samples with the 3-fold increased E. coli abun-
dance by adding the constant
1 S  meanhumanmeanE. coli (Eq. 4)
to all of these values. Here, mean(E. coli) is the average dif-
ference in log intensities between the two replicate groups for
the E. coli proteins, mean(human) is the same quantity calcu-
lated for all human proteins, and s is a scaling factor between
0 and 1. For s 1, the original data are recovered, whereas for
s  0 the mean ratio is 1:1 for all proteins, in particular for the
E. coli proteins. For a given value of s, the corresponding
simulated ratio is r  3s.
Fig. 5A shows precision-recall curves similar to those in Fig.
4A. This time, only the t test was used for determining signif-
icant changes, and we scanned through several values for the
simulated ratio r. As an example, we tolerated a proportion of
false discoveries (Q, the value estimated by the FDR) of 10%
for calling changes significant. Although in that case almost all
truly changing proteins are recovered with a ratio of 3, about
half of them are still obtained at a ratio of 1.6. Going below a
mean ratio change of 1.6 will lead to strong drop in coverage.
The FDR threshold that one wishes to apply depends on the
experimental situation and on the biological or technological
question. There is no a priori given FDR that is applicable to
every case. For instance, if pre-screening is done (e.g. to
explore regulated pathways or biological processes), a 25%
FDR might still be tolerable, whereas in other cases a 5% FDR
might not be stringent enough. To get an idea about the
relationship between protein ratio and coverage achieved for
proteins having this ratio, we plotted this dependence in Fig.
5B for several values of Q. In particular, for low stringency
there is a very rapid drop of coverage around a well-defined
ratio. For instance, the Q  0.25 curve has a steep slope
around a ratio of 1.4 where it achieves half of the coverage.
One could define this “half-coverage point” as the situation for
which it still makes sense to look for ratio changes. In Fig. 5C
we show the ratio at the point of half-coverage as a function
of Q. These ratios can achieve values of far less than 2 for
larger values of Q.
Dynamic Range Benchmark Set—So far, we have demon-
strated that MaxLFQ is able to accurately and robustly
quantify small fold changes on a proteome scale. This is
relevant, for instance, for the analysis of cellular proteome
remodeling upon stimulation. Next, we wanted to test the












































FIG. 4. Statistical significance of protein regulation. A, precision-recall curves based on four different strategies. TP, true positives; FP,
false positives; FN, false negatives. B, the Welch modified t test p value is plotted logarithmically against the ratio. The vast majority of E. coli
proteins (orange) have p values better than 0.05, indicating significant regulation. An extremely small number of human proteins (blue) appear
to have a large ratio and significant p value (false positives for quantification). The arrows indicate that the best strategy is to select significantly
regulated proteins by t test p value (first false positive after hundreds of correct hits with better p values) rather than fold change (first false
positive after three correct hits with higher fold change).
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ratios in the range of several orders of magnitude. Such
ratios typically occur in the context of interaction proteom-
ics experiments (56), where early mixing of isotope-labeled
samples is usually not possible and some of the principal ad-
vantages of metabolic labeling are therefore lost. We have re-
cently shown that both SILAC and MaxLFQ generate similar
ratio distributions (57), indicating that in such cases MaxLFQ is
capable of achieving quantification accuracies comparable to
those obtained with SILAC.
As a benchmark dataset for high protein ratios, we made
use of the universal protein standard (UPS) (Sigma-Aldrich), a
mixture of 48 recombinant human proteins that is available as
an equimolar mixture (UPS1) or mixed at defined ratios span-
ning 5 orders of magnitude (UPS2). This dataset does not
contain fractionation and is used for showing that MaxLFQ
performs well at high dynamic range quantification in general.
We separately digested UPS1 and UPS2 with trypsin and
spiked the peptides into a trypsin-digested E. coli lysate. We
analyzed each condition in four replicates via single-shot LC-
MS/MS. Raw data were processed as described for the pro-
teome benchmark dataset, with some exceptions as outlined
below. MaxQuant identified 232,835 isotope clusters by MS/
MS, and matching between runs increased the number of
quantifiable features by 38%. After protein inference, this
resulted in 2200 non-redundant E. coli protein groups. We
identified all of the 48 human UPS proteins in all samples
containing E. coli with the equimolar UPS1 standard (supple-
mental Table S2). In the sample of E. coli plus UPS2, 15 of the
lower abundant human UPS proteins were never sequenced
by MS/MS, but 10 of them could be identified and quantified
in at least some of the replicates through matching to the
UPS1-containing samples. Applying the same requirement
of two shared peptides for each pair-wise comparison (as
used in the proteome benchmark dataset) expectedly re-
sulted in missing values for samples in which only individual
peptides were found; therefore we lowered this threshold to
one. Extreme ratios typically coincide with very different
peptide populations identified in the samples to be com-
pared: many in the sample with high protein abundance, of
which only a small subset is found in the low-abundance
sample. This can make the protein ratio determination rely
on very few quantification events, which increases the sen-
sitivity to outliers. To address this issue, we implemented an
optional feature called “large ratio stabilization,” which
modifies the ratio determination for pair-wise comparisons
where the number of peptides quantified in the two samples
differs substantially. In a case when fewer than one out of
five peptides is shared between samples, the ratio of the
summed-up peptide intensities is taken for quantification. If
more than two out of five peptides are shared, the median of
pair-wise ratios is used. For intermediate cases, we inter-
polate linearly between these two kinds of ratio determina-
tions. In summary, the protein ratio r is determined by the
median of peptide ratios rm and the ratio of summed-up













































































FIG. 5. Statistical significance of
small protein ratios. A, precision-recall
curves based on a t test on a set of
ratios that were simulated in silico by
shrinking the experimental ratio of three.
B, ratio-coverage plots for these simu-
lated ratios at a set of fixed proportions
of false discoveries among the discov-
eries (Q). One can see a drop in cover-
age around a given ratio, which is par-
ticularly steep for large values of Q. C,
simulated ratio at which one achieves
half-coverage plotted against the value
of Q.
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r  rm if x 2.5rs if x 5
expw log rs 1w log rm otherwise
(Eq. 5)
where w  (x  2.5)/2.5 and x is the ratio of the number of
peptide features in the sample with the most peptide features to
the number of common peptide features. We found that this
stabilized the general ratio trend and reduced the outlier
sensitivity.
Fig. 6A shows the quantification results for samples contain-
ing UPS2 versus UPS1, plotted in the same way as in Fig. 3.
UPS proteins are clearly separated from the narrow cloud of
E. coli proteins and cluster in groups according to their relative
abundances. For further analysis, we subtracted the median of
the group of UPS proteins present in equal amounts in both
UPS1 and UPS2. In a direct comparison of true ratio versus the
MaxLFQ readout (Fig. 6B), we show that within 2 orders of
magnitude, we obtained quantification results that were ex-
tremely close to the expected values. For ratios of more than
100-fold, we detected increased scatter, but no systematic
error that would lead to an over- or underestimation of the ratio
(Fig. 6F). Summed intensities yielded very similar results within
2 orders of magnitude (Fig. 6C) but a small systematic under-
estimation of very large ratios (Fig. 6G). Spectral counts covered
2 orders of magnitude less than intensity-based methods, be-
cause there were no MS/MS events for all proteins of the lowest
two abundance groups in all UPS2-plus-E. coli samples (Fig.
6D). For proteins covered by MS/MS spectra in both UPS1 and
UPS2 samples, there was a pronounced systematic underesti-
mation of the ratio when calculating the ratio of spectral counts
(Fig. 6H). This clearly shows that spectral counting suffers from
a very narrow dynamic range that is limited by the total number
of identified MS/MS spectra. Of note, all methods unanimously
detected ratios of less than 10 for the comparison of the group
of most abundant proteins in the UPS2 samples. This leads us
to speculate that this was not due to a quantification error, but
rather due to the composition of the UPS2 peptide mixture. It is
possible that the eight most abundant proteins could be slightly
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FIG. 6. Quantification results for
the dynamic range benchmark data-
set. Replicate groups were filtered for
three out of four valid values and aver-
aged. A, log ratios of the UPS2 versus
UPS1 samples plotted against the log-
arithm of summed peptide intensities
from the UPS1 sample as a proxy for
absolute protein abundance. E. coli pro-
teins are plotted in gray and form a nar-
row population centered on zero. UPS
proteins are color-coded by their abun-
dance groups in the UPS2 sample. B–D,
to compare the ratio readout against the
true ratio, we shifted the population of
UPS proteins that were present in UPS1
and UPS2 in equimolar amounts to 1:1
and plotted the log ratio obtained from
(B) MaxLFQ, (C) summed intensities,
and (D) spectral counts against the log
of the true ratio. E, log intensity ratio
plotted against log MaxLFQ ratios. F–H,
data from B–D plotted as the deviation
from the true ratio. Spectral counts
show a clear underestimation of ratios
across the entire dynamic range and
lose 2 orders of magnitude. Summed
intensities and MaxLFQ show increased
scatter toward ratios of several orders
of magnitude. Summed intensities show
some degree of systematic underesti-
mation of large ratios, which was not
observed for MaxLFQ ratios.
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Fast Label-free Normalization of Large Datasets—In the
analysis of very large datasets, one of the computationally
most expensive steps is the determination of the normaliza-
tion factors for each LC-MS run by minimizing the quantity
H(N) described earlier and depicted in Fig. 1. This quantity
contains a sum running over all pairs of samples that grows
quadratically with the number of samples. (Note that in the
case of pre-fractionation, multiple LC-MS runs contribute to
one sample and do not contribute to a further quadratic
increase of the computational effort.) One approach would be
to do normalization in a more simplistic way and only use the
reconstruction of protein abundances based on paired pep-
tide ratios from MaxLFQ. However, because the normalization
is crucial with fractionated samples, we wanted to find an
algorithm that delivered results very similar to those of the full
MaxLFQ computation, but within a much smaller computation
time.
Because the resulting minimization problem becomes in-
creasingly overdetermined for larger numbers of samples, we
reasoned that a meaningful subset of comparisons would
significantly reduce the computing time while still delivering
correct normalization factors. Even a linear chain of compar-
isons in which every sample occurs exactly once would in
principle be sufficient to determine all normalization factors.
However, this minimal strategy may lead to unstable and
error-prone calculations, as the failure or imprecision of a
single comparison may propagate into the calculation of all
normalization factors. As a compromise considering stability,
correctness, and computational efficiency, a reasonable and
robust subset of pair-wise comparisons needs to be found.
We started by creating a graph with all samples as nodes. A
large overlap of peptides between each pair of nodes was
interpreted as a small distance between them. A subgraph was
then determined in which each node had a minimum number of
three nearest neighbors and the average number of neighbors
over all nodes was six. All edges that were not needed to fulfill
these criteria were removed while making sure that all nodes
remained connected. For the sum in H(N) in Fig. 1, only those
sample pairs were taken into account that had an edge in this
graph, resulting in linear scaling of the computational effort with
the number of samples. This “fast” normalization option can be
optionally activated in MaxQuant, and the parameters for sub-
graph determination are adjustable by the user.
DISCUSSION
We have introduced MaxLFQ as a suite of novel algorithms
for relative protein quantification without stable isotopes. “De-
layed normalization” efficiently solves the problem of how to
compare sample fractions that have been handled in slightly
different ways and analyzed with different MS performance.
Importantly, delayed normalization does not require “house-
hold” proteins, which are assumed to be unchanging in the
experiment. The only prerequisite is a dominant population
of proteins that change minimally between experimental
conditions. The second algorithm allows the retrieval of the
maximum possible information from peptide ratios across
samples, without resorting to arbitrary assignment of the
signal when a peptide signal cannot be detected. Finally, a
profile of “LFQ” intensities is calculated for each protein as
the best estimate satisfying all the pair-wise peptide com-
parisons. Importantly, this intensity profile retains the abso-
lute scale from the original summed-up peptide intensities.
This should readily qualify it as a proxy for absolute protein
abundance. MaxLFQ is a generic approach that works in-
dependently of the experimental question under investiga-
tion, and we have demonstrated equally good performance
for the determination of small and very large ratios. For
assessing the statistical significance of individual protein
ratios, we found that t testing on a dataset with three or
more replicates delivered the best results and was superior
to a simple fold-change cut-off.
Our laboratory has successfully used MaxLFQ in a num-
ber of studies with very diverse biological questions. For
instance, in measurements that spanned more than a year,
we studied the proteomic differences of rare immunological
cell types and found mutually exclusive expressions of pat-
tern recognition receptors (58). We have also followed the
proteome rearrangements during colon cancer develop-
ment and metastasis in the colon mucosa (54). Furthermore,
we have used label-free quantification to study protein–
protein interactions expressed as GFP-tagged constructs
from bacterial artificial chromosomes under endogenous
control (56) and screened for interactors of post-translation-
ally modified histone tails in mouse tissues (57). In that case
we showed that MaxLFQ achieved similar quantification
accuracies as SILAC. Interaction proteomics experiments
typically detect specific interactors with enrichment factors
on the order of several magnitudes. Here, the general ratio
trend is sometimes more important than a very accurate
readout of the actual ratio. Such cases offer a straightfor-
ward remedy for dealing with missing values: they can
simply be imputed as simulated values forming a distribu-
tion around the detection limit of measured intensities and
serve as the basis for judging enrichment factors. This is a
principal advantage over label-based ratio determination,
where dealing with infinite ratios is conceptually more
difficult.
In a very recent study, we used MaxLFQ to study the
secretome of activated immune cells and detected proteins
whose abundance was increased by several orders of mag-
nitude in the culture medium upon stimulation (59).
We have already been making MaxLFQ available as part of
the MaxQuant software for some time, and other groups have
made frequent use of it (60–75). It has also been bench-
marked against other software solutions for label-free quan-
tification (31), independently confirming the excellent per-
formance of our software.
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Recent advances in mass spectrometer hardware (76, 77)
have provided a boost in the depth of standard analyses and
enabled near-complete model proteome quantification in
minimal measuring time (6). Label-free quantification benefits
dramatically from this depth, as it increases the number of
quantifiable features present in a given LC-MS run and allows
averaging over more peptides for protein quantification. Illus-
trating this, in our dynamic-range benchmark dataset we re-
corded one of the largest published E. coli proteomes so far,
resulting in a high sequence coverage and hence a very
narrow cloud of E. coli protein quantifications.
Some challenges for label-free quantification remain: Sam-
ple handling variability needs to be minimized when samples
are to be recorded over the course of many months, on
different machines, or by different laboratories. Standardiza-
tion of instrumentation, simplification of sample preparation
procedures, and automation using multiwell systems or ro-
botics will help to mitigate this issue. Biological studies that
depend on the ultimate accuracy of the ratio readout or on
quantitative information about individual peptides, such as
post-translationally modified ones, will still rely on isotope
labels. In addition, applications that require extreme robust-
ness, such as sample handling in a clinical setting, will likely
benefit from spike-in references that serve as internal stand-
ards. That said, we expect label-free quantification methods in
general and MaxLFQ in particular to gain further momentum in
the proteomics community and become the method of choice
for many applications. The ease of use of MaxLFQ as part of the
MaxQuant software suite should enable our technology to be
widely adopted by nonspecialized labs as well.
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